Applied DNA Sciences Announces Proposed Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- S&P 500, Dow futures attempt recovery ahead of inflation report
- Oracle raises full year profit guidance, stock rises after hours
- Oil surges 6%, Brent and US crude both surpass $100 on more tanker attacks
- Analysts split on Apple after foldable iPhone Duo debut
- JPMorgan upgrades Meta on AI models and agents, sees 'meaningful headroom'
- White House copper tariff plan stalls amid affordability concerns, sources say
- Micron's Taiwan workers to get rewards worth up to 68 months of pay
- Crude Inventory 0.4M Barrels Last Week - EIA
- Vertiv shares drop on acquisition skepticism, AI pullback
- Copart nears $2B all-cash deal to acquire ACV Auctions - Bloomberg
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Applied DNA Sciences (APDN) Prices $11.46M Offering of Stock and Warrants
March 27, 2015 9:05 AM EDTApplied DNA Sciences, Inc. (NASDAQ: APDN) announced that it has priced its previously announced underwritten public offering of 3,820,000 shares of its common stock and warrants to purchase up to an aggregate of 1,528,000shares of common stock, at a combined public offering price of $3.00. The warrants have an exercise price of $3.50 per share, expire on November 20, 2019 and will trade under the symbol APDNW.
The gross proceeds to the Company from this offering are estimated to be approximately $11.46 million before deducting the underwriting discount and other... More
Applied DNA Sciences (APDN) Plans Common, Warrants Offering
March 26, 2015 4:28 PM EDTApplied DNA Sciences (NASDAQ: APDN) announced that it intends to offer shares of common stock and warrants to purchase common stock in an underwritten public offering. Maxim Group LLC will serve as the sole book runner for the offering with The Benchmark Company... More
